TheraCryf PLC (TCF)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.18p

Buy

0.22p

arrow-up0.00p (+0.00%)

Prices updated at 19 Dec 2025, 16:24 GMT

Prices minimum 15 mins delay

Prices in GBX

Evgen Pharma PLC is a clinical stage drug development company focused on cancer and neurological disease. Its pipeline is based on Sulforadex technology which includes synthetic and stabilized analogues of sulforaphane.

FTSE All-Share

0.53%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

To view this unique content please
log in or open an account

Prices shown are in the currency of the stock selected. For example, if a UK stock is chosen these figures are in sterling, if a US stock chosen then the figures shown are in dollars.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.